Protective effects of a compound herbal extract (Tong Xin Luo) on free fatty acid induced endothelial injury: Implications of antioxidant system

详细信息    查看全文

• 作者：Lin Zhang (1)
  Yiling Wu (2)
  Zhenhua Jia (2)
  Yun Zhang (3)
  Hu Ying Shen (1)
  Xing Li Wang (1)
  
• 刊名：BMC Complementary and Alternative Medicine
• 出版年：2008
• 出版时间：December 2008
• 年：2008
• 卷：8
• 期：1
• 全文大小：1078KB
• 参考文献：1. Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. / J Clin Endocrinol Metab 2007, 92:399-04. CrossRef
  2. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. 2004, 109:433-38.
  3. Uwaifo GI, Ratner RE: The roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular disease. / Am J Med 2003, 115 Suppl 8A:12S-19S. CrossRef
  4. Egan BM, Lu G, Greene EL: Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. / Prostaglandins Leukot Essent Fatty Acids 1999, 60:411-20. CrossRef
  5. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. / J Clin Invest 1997, 100:1230-239. CrossRef
  6. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD: Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. / Diabetes 2000, 49:1231-238. CrossRef
  7. Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, Johansen B: Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. / Arterioscler Thromb Vasc Biol 1997, 17:300-09.
  8. Dichtl W, Nilsson L, Goncalves I, Ares MP, Banfi C, Calara F, Hamsten A, Eriksson P, Nilsson J: Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. / Circ Res 1999, 84:1085-094.
  9. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P: Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. / Diabetes 2003, 52:2882-887. CrossRef
  10. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, Haring HU: Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. / Diabetes 2004, 53:3209-216. CrossRef
  11. Kim F, Tysseling KA, Rice J, Pham M, Haji L, Gallis BM, Baas AS, Paramsothy P, Giachelli CM, Corson MA, Raines EW: Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. / Arterioscler Thromb Vasc Biol 2005, 25:989-94. CrossRef
  12. Carlsson M, Wessman Y, Almgren P, Groop L: High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. / Arterioscler Thromb Vasc Biol 2000, 20:1588-594.
  13. Jouven X, Charles MA, Desnos M, Ducimetiere P: Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. / Circulation 2001, 104:756-61. CrossRef
  14. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. / Diabetes 1997, 46:3-0. CrossRef
  15. Wyne KL: Free fatty acids and type 2 diabetes mellitus. / Am J Med 2003, 115 Suppl 8A:29S-36S. CrossRef
  16. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, Schick F: Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. / Magn Reson Med 2001, 45:179-83. CrossRef
  17. Boden G: Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. / Exp Clin Endocrinol Diabetes 2003, 111:121-24. CrossRef
  18. McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. / Diabetes 2002, 51:7-8. CrossRef
  19. Stentz FB, Kitabchi AE: Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. / Biochem Biophys Res Commun 2006, 346:721-26. CrossRef
  20. Guo WX, Yang QD, Liu YH, Xie XY, Wang M, Niu RC: Palmitic and Linoleic Acids Impair Endothelial Progenitor Cells by Inhibition of Akt/eNOS Pathway. / Arch Med Res 2008, 39:434-42. CrossRef
  21. Best PJ, Hasdai D, Sangiorgi G, Schwartz RS, Holmes DR Jr., Simari RD, Lerman A: Apoptosis : basic concepts and implications in coronary artery disease. / Arterioscler Thromb Vasc Biol 1999, 19:14-2.
  22. Haunstetter A, Izumo S: Apoptosis: basic mechanisms and implications for cardiovascular disease. / Circ Res 1998, 82:1111-129.
  23. Bombeli T, Karsan A, Tait JF, Harlan JM: Apoptotic vascular endothelial cells become procoagulant. / Blood 1997, 89:2429-442.
  24. Li D, Yang B, Mehta JL: Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. / Am J Physiol 1998, 275:H568-6.
  25. Dimmeler S, Hermann C, Zeiher AM: Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? / Eur Cytokine Netw 1998, 9:697-98.
  26. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM: Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. / Circ Res 1997, 81:970-76.
  27. Wu T, Harrison RA, Chen X, Ni J, Zhou L, Qiao J, Wang Q, Wei J, Xin D, Zheng J: Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. / Cochrane Database Syst Rev 2006, CD004474.
  28. Qian HY, Yang YJ, Huang J, Gao RL, Dou KF, Yang GS, Li JJ, Shen R, He ZX, Lu MJ, Zhao SH: Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. / Chin Med J (Engl) 2007, 120:1416-425.
  29. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, Shen YH: Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. / Diabetes 2006, 55:2301-310. CrossRef
  30. Shen YH, Zhang L, Gan Y, Wang X, Wang J, Lemaire SA, Coselli JS, Wang XL: Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling: A CROSS-TALK BETWEEN STRESS SIGNALING AND INSULIN SIGNALING IN RESISTIN-TREATED HUMAN ENDOTHELIAL CELLS. / J Biol Chem 2006, 281:7727-736. CrossRef
  31. Long YC, Zierath JR: AMP-activated protein kinase signaling in metabolic regulation. / J Clin Invest 2006, 116:1776-783. CrossRef
  32. Arad M, Seidman CE, Seidman JG: AMP-activated protein kinase in the heart: role during health and disease. / Circ Res 2007, 100:474-88. CrossRef
  33. Fryer LG, Foufelle F, Barnes K, Baldwin SA, Woods A, Carling D: Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. / Biochem J 2002, 363:167-74. CrossRef
  34. Moslen MT: Reactive oxygen species in normal physiology, cell injury and phagocytosis. / Adv Exp Med Biol 1994, 366:17-7.
  35. Babior BM, Kipnes RS, Curnutte JT: Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. / J Clin Invest 1973, 52:741-44. CrossRef
  36. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. / Gastroenterology 1981, 81:22-9.
  37. Kaimul AM, Nakamura H, Masutani H, Yodoi J: Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. / Free Radic Biol Med 2007, 43:861-68. CrossRef
  38. Patwari P, Lee RT: Thioredoxins, mitochondria, and hypertension. / Am J Pathol 2007, 170:805-08. CrossRef
  39. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT: The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. / J Biol Chem 2006, 281:21884-1891. CrossRef
  40. Lillig CH, Holmgren A: Thioredoxin and related molecules--from biology to health and disease. / Antioxid Redox Signal 2007, 9:25-7. CrossRef
  41. World CJ, Yamawaki H, Berk BC: Thioredoxin in the cardiovascular system. / J Mol Med 2006, 84:997-003. CrossRef
  42. Calingasan NY, Park LC, Calo LL, Trifiletti RR, Gandy SE, Gibson GE: Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. / Am J Pathol 1998, 153:599-10.
  43. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. / J Clin Invest 1993, 92:1866-874. CrossRef
  44. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Nakashima Y, Ikeda M: Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. / J Biol Chem 1999, 274:2271-278. CrossRef
  45. Keaney JF Jr., Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA: Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. / J Clin Invest 1996, 98:386-94. CrossRef
  46. Moellering D, McAndrew J, Jo H, Darley-Usmar VM: Effects of pyrrolidine dithiocarbamate on endothelial cells: protection against oxidative stress. / Free Radic Biol Med 1999, 26:1138-145. CrossRef
  47. Ide N, Lau BH: S-allylcysteine attenuates oxidative stress in endothelial cells. / Drug Dev Ind Pharm 1999, 25:619-24. CrossRef
  48. Meydani M: Dietary antioxidants modulation of aging and immune-endothelial cell interaction. / Mech Ageing Dev 1999, 111:123-32. CrossRef
  49. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/8/39/prepub
  
• 作者单位：Lin Zhang (1)
  Yiling Wu (2)
  Zhenhua Jia (2)
  Yun Zhang (3)
  Hu Ying Shen (1)
  Xing Li Wang (1)
  
  1. Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Texas Heart Institute, Houston, Texas, USA
  2. Research Institute of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Hebei, PR China
  3. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Shandong University Qilu Hospital, Jinan, PR China
  

文摘

Background Tong-Xin-Luo (TXL) -a mixture of herbal extracts, has been used in Chinese medicine with established therapeutic efficacy in patients with coronary artery disease. Methods We investigated the protective role of TXL extracts on endothelial cells injured by a known risk factor -palmitic acid (PA), which is elevated in metabolic syndrome and associated with cardiovascular complications. Human aortic endothelial cells (HAECs) were preconditioned with TXL extracts before exposed to PA for 24 hours. Results We found that PA (0.5 mM) exposure induced 73% apoptosis in endothelial cells. However, when HAECs were preconditioned with ethanol extracted TXL (100 μg/ml), PA induced only 7% of the endothelial cells into apoptosis. Using antibody-based protein microarray, we found that TXL attenuated PA-induced activation of p38-MAPK stress pathway. To investigate the mechanisms involved in TXL's protective effects, we found that TXL reduced PA-induced intracellular oxidative stress. Through AMPK pathway, TXL restored the intracellular antioxidant system, which was depressed by the PA treatment, with an increased expression of thioredoxin and a decreased expression of the thioredoxin interacting protein. Conclusion In summary, our study demonstrates that TXL protects endothelial cells from PA-induced injury. This protection is likely mediated by boosting intracellular antioxidant capacity through AMPK pathway, which may account for the therapeutic efficacy in TXL-mediated cardiovascular protection.